ABBOTT LABORATORIES Quarterly Goodwill in USD from Q1 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Abbott Laboratories quarterly Goodwill history and growth rate from Q1 2010 to Q2 2024.
  • Abbott Laboratories Goodwill for the quarter ending June 30, 2024 was $23.3B, a 0.22% increase year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $23.3B +$50M +0.22% Jun 30, 2024 10-Q 2024-07-31
Q1 2024 $23.4B +$456M +1.99% Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $23.7B +$880M +3.86% Dec 31, 2023 10-Q 2024-07-31
Q3 2023 $23.3B +$993M +4.46% Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $23.3B +$514M +2.26% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $22.9B -$252M -1.09% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $22.8B -$432M -1.86% Dec 31, 2022 10-K 2024-02-16
Q3 2022 $22.3B -$1.02B -4.36% Sep 30, 2022 10-Q 2022-11-01
Q2 2022 $22.7B -$741M -3.16% Jun 30, 2022 10-Q 2022-08-02
Q1 2022 $23.2B -$205M -0.88% Mar 31, 2022 10-Q 2022-05-03
Q4 2021 $23.2B -$513M -2.16% Dec 31, 2021 10-K 2023-02-17
Q3 2021 $23.3B -$39M -0.17% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $23.5B +$403M +1.75% Jun 30, 2021 10-Q 2021-08-04
Q1 2021 $23.4B +$457M +1.99% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 $23.7B +$549M +2.37% Dec 31, 2020 10-K 2022-02-18
Q3 2020 $23.3B +$292M +1.27% Sep 30, 2020 10-Q 2020-11-04
Q2 2020 $23.1B -$247M -1.06% Jun 30, 2020 10-Q 2020-07-29
Q1 2020 $22.9B -$282M -1.22% Mar 31, 2020 10-Q 2020-04-29
Q4 2019 $23.2B -$59M -0.25% Dec 31, 2019 10-K 2021-02-19
Q3 2019 $23B -$370M -1.58% Sep 30, 2019 10-Q 2019-10-31
Q2 2019 $23.3B -$515M -2.16% Jun 30, 2019 10-Q 2019-07-31
Q1 2019 $23.2B -$1.02B -4.2% Mar 31, 2019 10-Q 2019-05-01
Q4 2018 $23.3B -$766M -3.19% Dec 31, 2018 10-K 2020-02-21
Q3 2018 $23.4B +$1.35B +6.12% Sep 30, 2018 10-Q 2018-10-31
Q2 2018 $23.8B +$1.71B +7.74% Jun 30, 2018 10-Q 2018-08-01
Q1 2018 $24.2B +$2.87B +13.5% Mar 31, 2018 10-Q 2018-05-02
Q4 2017 $24B +$16.3B +213% Dec 31, 2017 10-K 2019-02-22
Q3 2017 $22.1B +$14.3B +182% Sep 30, 2017 10-Q 2017-11-02
Q2 2017 $22.1B +$12.4B +127% Jun 30, 2017 10-Q 2017-08-02
Q1 2017 $21.4B +$11.6B +118% Mar 31, 2017 10-Q 2017-05-03
Q4 2016 $7.68B -$1.96B -20.3% Dec 31, 2016 10-K 2018-02-16
Q3 2016 $7.81B -$1.94B -19.9% Sep 30, 2016 10-Q 2016-11-03
Q2 2016 $9.75B -$144M -1.46% Jun 30, 2016 10-Q 2016-08-03
Q1 2016 $9.78B -$80M -0.81% Mar 31, 2016 10-Q 2016-05-04
Q4 2015 $9.64B -$429M -4.26% Dec 31, 2015 10-K 2017-02-17
Q3 2015 $9.75B -$298M -2.97% Sep 30, 2015 10-Q 2015-11-05
Q2 2015 $9.9B +$145M +1.49% Jun 30, 2015 10-Q 2015-08-04
Q1 2015 $9.86B +$74M +0.76% Mar 31, 2015 10-Q 2015-05-06
Q4 2014 $10.1B +$295M +3.02% Dec 31, 2014 10-K 2016-02-19
Q3 2014 $10B +$324M +3.33% Sep 30, 2014 10-Q 2014-11-06
Q2 2014 $9.75B +$393M +4.21% Jun 30, 2014 10-Q 2014-08-05
Q1 2014 $9.78B +$356M +3.78% Mar 31, 2014 10-Q 2014-05-07
Q4 2013 $9.77B -$6B -38.1% Dec 31, 2013 10-K 2015-02-27
Q3 2013 $9.72B -$5.98B -38.1% Sep 30, 2013 10-Q 2013-11-07
Q2 2013 $9.36B -$6B -39.1% Jun 30, 2013 10-Q 2013-08-06
Q1 2013 $9.42B -$6.48B -40.7% Mar 31, 2013 10-Q 2013-05-08
Q4 2012 $15.8B +$68.6M +0.44% Dec 31, 2012 10-K 2014-02-21
Q3 2012 $15.7B -$522M -3.22% Sep 30, 2012 10-Q 2012-11-07
Q2 2012 $15.4B -$1.4B -8.36% Jun 30, 2012 10-Q 2012-08-07
Q1 2012 $15.9B -$726M -4.36% Mar 31, 2012 10-Q 2012-05-08
Q4 2011 $15.7B -$225M -1.41% Dec 31, 2011 10-K 2013-02-15
Q3 2011 $16.2B +$424M +2.68% Sep 30, 2011 10-Q 2011-11-04
Q2 2011 $16.8B +$2.54B +17.9% Jun 30, 2011 10-Q 2011-08-04
Q1 2011 $16.6B +$1.62B +10.8% Mar 31, 2011 10-Q 2011-05-06
Q4 2010 $15.9B Dec 31, 2010 10-K 2013-02-15
Q3 2010 $15.8B Sep 30, 2010 10-Q 2010-11-05
Q2 2010 $14.2B Jun 30, 2010 10-Q 2010-08-05
Q1 2010 $15B Mar 31, 2010 10-Q 2010-05-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.